Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Total Debt Over TimeNormalizing
Percentile Rank78
3Y CAGR+24.7%
5Y CAGR-29.8%
Studio
Year-over-Year Change

Sum of short-term and long-term debt obligations

3Y CAGR
+24.7%/yr
Annual compound
5Y CAGR
-29.8%/yr
Recent acceleration
Percentile
P78
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineNormalizing
PeriodValueYoY Change
2025$14.51M-44.3%
2024$26.04M+276.5%
2023$6.92M-7.5%
2022$7.48M+60.5%
2021$4.66M-94.5%
2020$85.04M+689.0%
2019$10.78M-
2018$0.00-100.0%
2013$5.32M-2.1%
2012$5.44M-